Community health centers face trouble after public health emergency ends
A combination of lost Medicaid reimbursements, expiring policy flexibilities and a funding cliff worry community health center leaders.
Senate finance leaders propose bill to expand telehealth for mental healthcare
The lawmakers want to preserve telehealth flexibilities created during the COVID-19 pandemic, focusing on Medicare, Medicaid and schools.
HHS scraps Trump-era SUNSET rule that mandated regulatory reviews
Betting on ‘Golden Age’ of colonoscopies, private equity invests in gastro docs
An aging population in need of regular cancer screenings has driven private equity companies, seeking profits, to invest in many gastroenterology practices and set up aggressive billing practices.
CVS Health launches virtual primary care platform
Starting in 2023, Aetna and CVS Caremark members will be able to access remote care teams, virtual care services and their own interoperable electronic health record.
'Long COVID' poses unique challenges for providers seeking answers
Burned out by COVID and 80-hour workweeks, resident physicians unionize
More than 1,300 unionized residents and other trainees at three L.A. County public hospitals will vote May 30 on whether to strike for a bump in their salaries and housing stipends, after a monthslong negotiation deadlock with the county.
MH Magazine Exclusive
Designing health facilities with DEI in mind
New concepts focus on personalization and patient experience.
Sick kids, anxious parents turn to hospitals amid formula shortage
Physician compensation rebounded slightly in 2021, study shows
ProMedica promotes COO Arturo Polizzi to president
MH Magazine Exclusive
Q&A with Antonio Ciaccia of 3 Axis Advisors: ‘PBMs aren’t really PBMs anymore’
Antonio Ciaccia, CEO of drug pricing research firm 46brooklyn Research and president of 3 Axis Advisors, discusses what’s driving payer lawsuits against pharmacy benefit managers, and the role these middlemen play in determining drug prices.
Dominant coronavirus mutant contains ghost of pandemic past
The coronavirus mutant that is now dominant in the U.S. is a member of the omicron family but scientists say it spreads faster than its omicron predecessors.
MH Magazine Exclusive
Commentary: A starting point for better conflict management and resolution
Conflict often stems from unmet expectations, and let’s face it, we have a lot of those in healthcare right now.
Novavax missed Its global moonshot but is angling to win over mRNA defectors
Although the U.S. commitment eventually expanded to $1.8 billion, hardly any Novavax shots have found arms due to manufacturing issues, and most of the world has moved on.
U.S. making COVID antiviral drug more available at test sites
The nation’s first federally backed test-to-treat site is opening Thursday in Rhode Island, providing patients with immediate access to the drug once they test positive. More federally supported sites are set to open in the coming weeks.